These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


217 related items for PubMed ID: 18363520

  • 1. Armodafinil: a new treatment for excessive sleepiness.
    Lankford DA.
    Expert Opin Investig Drugs; 2008 Apr; 17(4):565-73. PubMed ID: 18363520
    [Abstract] [Full Text] [Related]

  • 2. Armodafinil for excessive daytime sleepiness.
    Nishino S, Okuro M.
    Drugs Today (Barc); 2008 Jun; 44(6):395-414. PubMed ID: 18596995
    [Abstract] [Full Text] [Related]

  • 3. Tolerability and efficacy of armodafinil in naïve patients with excessive sleepiness associated with obstructive sleep apnea, shift work disorder, or narcolepsy: a 12-month, open-label, flexible-dose study with an extension period.
    Schwartz JR, Khan A, McCall WV, Weintraub J, Tiller J.
    J Clin Sleep Med; 2010 Oct 15; 6(5):450-7. PubMed ID: 20957845
    [Abstract] [Full Text] [Related]

  • 4. The long-term tolerability and efficacy of armodafinil in patients with excessive sleepiness associated with treated obstructive sleep apnea, shift work disorder, or narcolepsy: an open-label extension study.
    Black JE, Hull SG, Tiller J, Yang R, Harsh JR.
    J Clin Sleep Med; 2010 Oct 15; 6(5):458-66. PubMed ID: 20957846
    [Abstract] [Full Text] [Related]

  • 5. Armodafinil in the treatment of excessive sleepiness.
    Bogan RK.
    Expert Opin Pharmacother; 2010 Apr 15; 11(6):993-1002. PubMed ID: 20307223
    [Abstract] [Full Text] [Related]

  • 6. Armodafinil.
    Garnock-Jones KP, Dhillon S, Scott LJ.
    CNS Drugs; 2009 Sep 15; 23(9):793-803. PubMed ID: 19689169
    [Abstract] [Full Text] [Related]

  • 7. Adjunct armodafinil improves wakefulness and memory in obstructive sleep apnea/hypopnea syndrome.
    Hirshkowitz M, Black JE, Wesnes K, Niebler G, Arora S, Roth T.
    Respir Med; 2007 Mar 15; 101(3):616-27. PubMed ID: 16908126
    [Abstract] [Full Text] [Related]

  • 8. The efficacy and safety of armodafinil as treatment for adults with excessive sleepiness associated with narcolepsy.
    Harsh JR, Hayduk R, Rosenberg R, Wesnes KA, Walsh JK, Arora S, Niebler GE, Roth T.
    Curr Med Res Opin; 2006 Apr 15; 22(4):761-74. PubMed ID: 16684437
    [Abstract] [Full Text] [Related]

  • 9. Modafinil : a review of its use in excessive sleepiness associated with obstructive sleep apnoea/hypopnoea syndrome and shift work sleep disorder.
    Keating GM, Raffin MJ.
    CNS Drugs; 2005 Apr 15; 19(9):785-803. PubMed ID: 16142993
    [Abstract] [Full Text] [Related]

  • 10. Systemic exposure to armodafinil and its tolerability in healthy elderly versus young men: an open-label, multiple-dose, parallel-group study.
    Darwish M, Kirby M, Hellriegel ET, Yang R, Robertson P.
    Drugs Aging; 2011 Feb 01; 28(2):139-50. PubMed ID: 21275439
    [Abstract] [Full Text] [Related]

  • 11. Armodafinil for treatment of excessive sleepiness associated with shift work disorder: a randomized controlled study.
    Czeisler CA, Walsh JK, Wesnes KA, Arora S, Roth T.
    Mayo Clin Proc; 2009 Nov 01; 84(11):958-72. PubMed ID: 19880686
    [Abstract] [Full Text] [Related]

  • 12. Effects of Modafinil and Armodafinil in Patients With Obstructive Sleep Apnea: A Meta-analysis of Randomized Controlled Trials.
    Kuan YC, Wu D, Huang KW, Chi NF, Hu CJ, Chung CC, Tam KW, Huang YH.
    Clin Ther; 2016 Apr 01; 38(4):874-88. PubMed ID: 26923035
    [Abstract] [Full Text] [Related]

  • 13. Armodafinil, the R-enantiomer of modafinil: wake-promoting effects and pharmacokinetic profile in the rat.
    Wisor JP, Dement WC, Aimone L, Williams M, Bozyczko-Coyne D.
    Pharmacol Biochem Behav; 2006 Nov 01; 85(3):492-9. PubMed ID: 17134745
    [Abstract] [Full Text] [Related]

  • 14. Randomized trial of modafinil for the treatment of pathological somnolence in narcolepsy. US Modafinil in Narcolepsy Multicenter Study Group.
    Ann Neurol; 1998 Jan 01; 43(1):88-97. PubMed ID: 9450772
    [Abstract] [Full Text] [Related]

  • 15. Modafinil in the treatment of excessive daytime sleepiness.
    Valentino RM, Foldvary-Schaefer N.
    Cleve Clin J Med; 2007 Aug 01; 74(8):561-6, 568-71. PubMed ID: 17708127
    [Abstract] [Full Text] [Related]

  • 16. Effects of modafinil on wakefulness and executive function in patients with narcolepsy experiencing late-day sleepiness.
    Schwartz JR, Nelson MT, Schwartz ER, Hughes RJ.
    Clin Neuropharmacol; 2004 Aug 01; 27(2):74-9. PubMed ID: 15252267
    [Abstract] [Full Text] [Related]

  • 17. Armodafinil improves wakefulness and long-term episodic memory in nCPAP-adherent patients with excessive sleepiness associated with obstructive sleep apnea.
    Roth T, Rippon GA, Arora S.
    Sleep Breath; 2008 Mar 01; 12(1):53-62. PubMed ID: 17874255
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of the abuse liability of modafinil and other drugs for excessive daytime sleepiness associated with narcolepsy.
    Jasinski DR, Kovacević-Ristanović R.
    Clin Neuropharmacol; 2000 Mar 01; 23(3):149-56. PubMed ID: 10895398
    [Abstract] [Full Text] [Related]

  • 19. Modafinil/armodafinil in obstructive sleep apnoea: a systematic review and meta-analysis.
    Chapman JL, Vakulin A, Hedner J, Yee BJ, Marshall NS.
    Eur Respir J; 2016 May 01; 47(5):1420-8. PubMed ID: 26846828
    [Abstract] [Full Text] [Related]

  • 20. Armodafinil and modafinil in patients with excessive sleepiness associated with shift work disorder: a pharmacokinetic/pharmacodynamic model for predicting and comparing their concentration-effect relationships.
    Darwish M, Bond M, Ezzet F.
    J Clin Pharmacol; 2012 Sep 01; 52(9):1328-42. PubMed ID: 22039290
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.